We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

4th Circ. Frees Pfizer From Antitrust Suit Over Celebrex Patent

Law360, New York (December 7, 2017, 3:50 PM EST) -- The Fourth Circuit on Thursday granted an unopposed motion to dismiss an antitrust suit brought against Pfizer Inc. by a putative class of health benefits plans that alleged the company used anti-competitive practices to get a patent for the inflammation medication Celebrex.

The appeals court granted the request the same day that the motion was filed. In October, the eight plans — including United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund and Wisconsin Masons’ Health Care Fund — asked the Fourth Circuit...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.